Enter your email address below to unsubscribe from INBRIJATM communications.
Treats OFF periods in adults taking carbidopa/levodopa (CD/LD). INBRIJA doesn’t replace CD/LD.
Don’t use if you have taken a nonselective monoamine oxidase inhibitor (eg, phenelzine, tranylcypromine) within the last 2 weeks.
INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa medicine.
Before using INBRIJA, tell your healthcare provider about your medical conditions, including:
Tell your healthcare provider if you take:
Tell your healthcare provider if you experience the following side effects:
Do not orally inhale more than 1 dose (2 capsules) for any OFF period. Do not take more than 5 doses (10 capsules) in a day.
Please see the Patient Information Leaflet.
You are about to leave Inbrija.com
Please Note: By clicking on this link, you are about to leave Inbrija.com, a website owned and operated by Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc., provides these links as a service to its website visitors and users; however, it does not endorse or take any responsibility for the information presented on any websites but its own.
You are sharing:
Many people are being asked to stay home to slow the spread of COVID-19. INBRIJA® (levodopa inhalation powder) continues to be delivered directly to patients' residences, so you can still receive your medication even if you are homebound for a prolonged period of time.
Prescription Support Services is fully functional and remains available to help you with access, reimbursement, and assistance for INBRIJA. At any time, if you have questions, please contact Prescription Support Services at 1‑888‑887‑3447. Prescription Support Services specialists are available to assist you Monday through Friday from 8 AM to 8 PM eastern time. Also, please visit us online at INBRIJA.com/prescription‑support‑services.
If you have questions or concerns about your treatment plan, please consult your doctor.
If you have questions or concerns related to INBRIJA, please feel free to reach out to us at 1‑800‑367‑5109 or firstname.lastname@example.org.